APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 50 filers reported holding APTINYX INC in Q3 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $13,071 | +477.9% | 104,736 | +1221.3% | 0.00% | – |
Q4 2022 | $2,262 | -24.6% | 7,927 | -0.0% | 0.00% | – |
Q3 2022 | $3,000 | -92.1% | 7,928 | -88.3% | 0.00% | – |
Q2 2022 | $38,000 | -80.2% | 67,841 | -19.7% | 0.00% | – |
Q1 2022 | $192,000 | -65.5% | 84,534 | -59.5% | 0.00% | – |
Q4 2021 | $556,000 | +8.2% | 208,678 | -4.9% | 0.00% | – |
Q3 2021 | $514,000 | -39.0% | 219,440 | -26.3% | 0.00% | – |
Q2 2021 | $842,000 | -24.4% | 297,584 | -19.9% | 0.00% | – |
Q1 2021 | $1,114,000 | -47.6% | 371,361 | -39.6% | 0.00% | – |
Q4 2020 | $2,127,000 | +19236.4% | 614,663 | +18128.4% | 0.00% | – |
Q3 2020 | $11,000 | -93.0% | 3,372 | -91.0% | 0.00% | – |
Q2 2020 | $157,000 | -18.7% | 37,594 | -57.8% | 0.00% | – |
Q1 2020 | $193,000 | -22.8% | 89,189 | +22.0% | 0.00% | – |
Q4 2019 | $250,000 | -84.4% | 73,097 | -84.1% | 0.00% | – |
Q3 2019 | $1,607,000 | +176.6% | 460,371 | +164.5% | 0.00% | – |
Q2 2019 | $581,000 | -72.0% | 174,039 | -66.0% | 0.00% | -100.0% |
Q1 2019 | $2,076,000 | +484.8% | 512,560 | +2291.8% | 0.00% | – |
Q4 2018 | $355,000 | -44.8% | 21,430 | -3.4% | 0.00% | – |
Q3 2018 | $643,000 | +2695.7% | 22,190 | +2226.0% | 0.00% | – |
Q2 2018 | $23,000 | – | 954 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
Orbimed Advisors | 538,500 | $300,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |